Dr. Jovana Zivanović is a fourth-year nuclear medicine resident specializing in molecular imaging, theranostics, and dosimetry-based radionuclide therapy. She has clinical and research experience in PET/CT, SPECT/CT, and individualized dosimetry for ¹⁷⁷Lu-DOTATATE and other targeted therapies.
Trained at the University Clinical Centre of Serbia, King’s College Hospital (London), and University Hospital Innsbruck (Austria), she combines clinical practice with translational research in quantitative imaging and radiopharmaceutical development.
As Scientific Communication Coordinator and Managing Committee Member of COST Action CA22118 – RATIONALE, she contributes to European collaboration in theranostics through research dissemination and outreach. Her work aims to advance personalized, data-driven approaches in nuclear medicine for improved patient care.